Suggestions
Natalie Rasgon
Director, Center for Neuroscience in Women’s Health, Stanford School of Medicine
Natalie Rasgon, MD, PhD, is a distinguished medical professional and researcher with extensive experience in psychiatry, women's health, and neuroscience. She is the co-founder of the Psychopathology and Allostatic Load Across the Life Span (PALS) Network.13
Professional Positions
Dr. Rasgon holds several prominent positions:
- Professor of Psychiatry and Obstetrics and Gynaecology at Stanford University1
- Director of the Center for Neuroscience in Women's Health at Stanford University School of Medicine23
- Visiting Professor at Rockefeller University2
Research Focus
Dr. Rasgon's research interests include:
- Mental illness and multiple comorbidities, particularly endocrine disorders and cardiometabolic risk factors1
- The role of insulin resistance in dementia, depression, and diabetes (which she refers to as the "3Ds")2
- Hormonal interventions during menopause as a treatment for mood disorders2
- Connections between insulin resistance and cognitive aging2
Expertise and Recognition
With over 40 years of experience, Dr. Rasgon is recognized as:
- An expert in complex diagnostic cases, both nationally and internationally1
- A leader in exploring the role of insulin resistance in mental and physical health2
- An internationally known thought leader in the neurobiology of stress and neuroscience in women's mental health4
She has received notable recognition, including the 2015 American Medical Women's Association's Lila Wallis Award for her contributions to women's health.2
Professional Affiliations
Dr. Rasgon is actively involved in various professional organizations:
- Member of the board of directors of the National Network of Depression Center2
- Founder of the Stanford Center for Neuroscience in Women's Health2
- Co-founder of the PALS Network, an international research collaborative network5
Through her work with the PALS Network, Dr. Rasgon aims to transform windows of vulnerability to mental and physical disorders into opportunities for health promotion and disease prevention.6